Reading time is 1 mins
.
.
WHO OFFICIAL ANNOUNCES: WE CAN END THE CORONAVIRUS EPIDEMIC IN 2022
The leader of the Covid-19 technical delegation to the World Health Organization (WHO), said she was “extremely hopeful” that the epidemic would end in 2022.
Answering questions about the Covid-19 pandemic and the new variant Omicron, said: “I am incredibly optimistic that 2022 will be the year of the end of the Covid-19 pandemic,” Euronews reported. Noting that the Omicron variant is spreading rapidly, stated that this variant has a growth advantage over Delta in some countries.
The WHO representative reported that they have studied in detail how the variant spreads in different populations, again, how a different immune system is seen in populations against it, comparing it with other previous variants.
The WHO representative, who spoke optimistically about the end of the Covid-19 pandemic next year, noted that they have much more opportunities to reduce the impact of the epidemic, reduce the death toll and hospitalizations.
.
OMICRON IS EXPECTED TO BE THE DOMINANT VARIANT IN EUROPE IN THE FIRST TWO MONTHS OF 2022
Meanwhile, the European Center for Disease Prevention and Control (ECDC) announced that the Covid-19 Omicron variant is expected to become the dominant variant on the European continent in the first two months of 2022. The ECDC’s updated risk assessment report included the expectation that the variant would spread “very rapidly” in European countries over the next few months.
The report stressed that Delta continues to be the dominant variant at the moment, but it is highly likely that Omicron will become dominant in Europe within the first two months of next year.
Director of the ECDC, said they see a “very high probability” that Omicron will spread rapidly.
“It is considered that Omicron is very transfer likely to increase the number of deaths and hospitalizations in addition to the predictions that previously considered the Delta variant,” said.
WHO Director-General said that the Omicron variant has been detected in 77 countries around the world, but this number is much higher. Epidemic measures had been increased in many European countries after the detection of the Omicron variant at the end of November 2021.
.
.
.
.
Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.
Physician's Resume:
Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.
Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.
In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.
Awards:
Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.
Certificates:
Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .
Professional Members:
American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.
Disclaimer:
Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.